Miu Wong - Shandong Weigao Company Secretary

SHWGY Stock  USD 2.08  0.12  5.45%   

Executive

Ms. Wong Miu Ling is a Company Secretary of Shandong Weigao Group Medical Polymer Company Limited. Ms. Wong joined the Company in May 2006. She is an fellowship member of both the Hong Kong Institute of Chartered Secretaries and the Institute of Chartered Secretaries and Administrators. Ms. Wong has over 18 years of experience in corporate finance and management.
Age 54
Phone86 63 1562 1999
Webhttps://www.weigaogroup.com

Shandong Weigao Management Efficiency

The company has return on total asset (ROA) of 0.0604 % which means that it generated a profit of $0.0604 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1276 %, meaning that it generated $0.1276 on every $100 dollars invested by stockholders. Shandong Weigao's management efficiency ratios could be used to measure how well Shandong Weigao manages its routine affairs as well as how well it operates its assets and liabilities.
Shandong Weigao Group has accumulated 3.46 B in total debt with debt to equity ratio (D/E) of 0.2, which may suggest the company is not taking enough advantage from borrowing. Shandong Weigao Group has a current ratio of 2.93, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Shandong Weigao until it has trouble settling it off, either with new capital or with free cash flow. So, Shandong Weigao's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Shandong Weigao Group sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Shandong to invest in growth at high rates of return. When we think about Shandong Weigao's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

EXECUTIVE Age

Warren FoustSTAAR Surgical
49
Kimberly CornwellRepligen
N/A
Alisha JerauldMerit Medical Systems
N/A
Mark FoxUtah Medical Products
N/A
Ricardo AlvarezMerit Medical Systems
N/A
Scott CenteaAngioDynamics
45
Saleem CheeksAngioDynamics
N/A
Stefano GrassiEssilorLuxottica Socit anonyme
50
Claudia OrtizEnvista Holdings Corp
N/A
Teresa FerragamoRepligen
N/A
MS MBANephros
50
Magda MichnaSTAAR Surgical
N/A
Brian KoopmanUtah Medical Products
55
Jason GarlandRepligen
51
Neil WhitfieldRepligen
N/A
Brian MooreSTAAR Surgical
N/A
Juan SernaAngioDynamics
N/A
Sarah ComstockMerit Medical Systems
N/A
Leslie GalvinRepligen
N/A
Kaushik GhoshalResMed Inc
57
Stephen KellerEnvista Holdings Corp
51
Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, and sale of single-use medical devices in the Peoples Republic of China. The company was incorporated in 2000 and is based in Weihai, the Peoples Republic of China. Shandong Weigao operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. It employs 11476 people. Shandong Weigao Group [SHWGY] is a Pink Sheet which is traded between brokers as part of OTC trading.

Management Performance

Shandong Weigao Group Leadership Team

Elected by the shareholders, the Shandong Weigao's board of directors comprises two types of representatives: Shandong Weigao inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Shandong. The board's role is to monitor Shandong Weigao's management team and ensure that shareholders' interests are well served. Shandong Weigao's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Shandong Weigao's outside directors are responsible for providing unbiased perspectives on the board's policies.
Junqiang Lu, Ex Director
Shili Ni, Ex Director
Miu Wong, Company Secretary
Hong Ju, Vice-General Manager of the Production and Supply Chain
Rinan Cong, CEO Director
Xue Wu, Chief Officer
Jing Long, Vice-General Manager of Marketing Management

Shandong Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Shandong Weigao a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Shandong Pink Sheet Analysis

When running Shandong Weigao's price analysis, check to measure Shandong Weigao's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Shandong Weigao is operating at the current time. Most of Shandong Weigao's value examination focuses on studying past and present price action to predict the probability of Shandong Weigao's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Shandong Weigao's price. Additionally, you may evaluate how the addition of Shandong Weigao to your portfolios can decrease your overall portfolio volatility.